Edson Bueno - UnitedHealth Group Director

UNH Stock  USD 494.70  1.60  0.32%   

Director

Dr. Edson Bueno M.D. is Director of UnitedHealth Group Inc. Dr. Bueno is the founder and CEO of Amil Assistncia Mdica Internacional S.A., formerly Amil Participaes S.A., in which UnitedHealth Group owns a 90 interest. Founded in 1978, Amil is the largest health care company in Brazil since 2012.
Age 71
Tenure 12 years
Address UnitedHealth Group Center, Minnetonka, MN, United States, 55343
Phone952 936 1300
Webhttps://www.unitedhealthgroup.com
Bueno holds a medical degree from the Federal University of Rio de Janeiro, with specialization in general surgery. He has attended courses in the Business Administration program at the Pontifical Catholic University of Rio de Janeiro and management programs at Harvard Business School.

UnitedHealth Group Management Efficiency

The company has Return on Asset of 0.0779 % which means that on every $100 spent on assets, it made $0.0779 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2499 %, implying that it generated $0.2499 on every 100 dollars invested. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities. The UnitedHealth Group's current Return On Equity is estimated to increase to 0.26, while Return On Capital Employed is projected to decrease to 0.15. As of now, UnitedHealth Group's Total Current Assets are increasing as compared to previous years. The UnitedHealth Group's current Intangible Assets is estimated to increase to about 16 B, while Non Currrent Assets Other are projected to decrease to under 10.9 B.
The company has 67.44 B in debt with debt to equity (D/E) ratio of 0.59, which is OK given its current industry classification. UnitedHealth Group has a current ratio of 0.76, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist UnitedHealth Group until it has trouble settling it off, either with new capital or with free cash flow. So, UnitedHealth Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UnitedHealth Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UnitedHealth to invest in growth at high rates of return. When we think about UnitedHealth Group's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 13 records

DIRECTOR Age

Siddhartha SankaranOscar Health
46
Vicki EscarraCentene Corp
60
John RobertsCentene Corp
78
Pamela JosephCentene Corp
56
Orlando AyalaCentene Corp
64
Richard GephardtCentene Corp
79
William TrubeckCentene Corp
74
Lori RobinsonCentene Corp
62
Tommy ThompsonCentene Corp
78
Frederick EppingerCentene Corp
62
David StewardCentene Corp
68
Jessica BlumeCentene Corp
66
Robert DitmoreCentene Corp
86
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. Unitedhealth operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 350000 people. UnitedHealth Group Incorporated (UNH) is traded on New York Stock Exchange in USA. It is located in UnitedHealth Group Center, Minnetonka, MN, United States, 55343 and employs 440,000 people. UnitedHealth Group is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

UnitedHealth Group Leadership Team

Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gail Wilensky, Independent Director
Timothy, Independent Director
Richard Burke, Independent Chairman of the Board
Valerie Rice, Independent Director
Andrew Witty, Group President, Chief Executive Officer, Executive Vice President, Director
Terry Clark, Executive Officer
Sir Witty, CEO Director
Stephen Hemsley, Non-Executive Chairman of the Board
John Rex, Chief Financial Officer, Executive Vice President
Dirk McMahon, President and Chief Operating Officer; Chief Executive Officer of UnitedHealthcare
DEllen Wilson, Executive Vice President - Human Capital
Steven Nelson, Executive Vice President CEO of UnitedHealthcare
Zachary Sopcak, Senior Relations
William McNabb, Independent Director
John Noseworthy, Independent Director
Larry Renfro, Vice Chairman and CEO of Optum
Robert Darretta, Independent Director
Jennifer Smoter, Senior Officer
William Ballard, Independent Director
Glenn Renwick, Independent Director
Rupert Bondy, Ex Officer
Sandeep Dadlani, Executive Officer
Michele Hooper, Lead Independent Director
Timothy Flynn, Independent Director
Thomas Roos, Senior Vice President, Chief Accounting Officer
Rodger Lawson, Independent Director
Frances Jacobs, IR Contact Officer
Matthew Friedrich, Executive Vice President Chief Legal Officer
Kenneth Shine, Independent Director
Edson Bueno, Director
D Wilson, Executive Vice President - Human Capital
F McNabb, Independent Director
Paul Garcia, Independent Director
Marianne Short, Executive Vice President, Chief Legal Officer
David Wichmann, Chief Executive Officer, Director
Patricia Lewis, Chief Human Resource Officer, Executive Vice President
Brian Thompson, Executive UnitedHealthcare
James Barry, Director Pennsylvania

UnitedHealth Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for UnitedHealth Stock analysis

When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
CEOs Directory
Screen CEOs from public companies around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.16
Dividend Share
7.29
Earnings Share
23.87
Revenue Per Share
400.455
Quarterly Revenue Growth
0.141
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.